Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Efficient in vitro screening for drug combinations: The TEVA model

Dr Angel Porgador - Ben-Gurion University of the Negev, Beersheeba, Israel
Efficient in vitro screening for drug combinations: The TEVA model ( Dr Angel Porgador - Ben-Gurion University of the Negev, Beersheeba, Israel )
10 Jul 2019

SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in patients with advanced metastatic NSCLC

Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in patients with advanced metastatic NSCLC ( Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA )
10 Jul 2019

Oncobox, RNA sequencing and molecular pathway analysis-base system for prescription of target drugs to advanced cancer patients

Dr Anton Buzdin - Sechenov Moscow First Medical University, Moscow, Russia
Oncobox, RNA sequencing and molecular pathway analysis-base system for prescription of target drugs to advanced cancer patients ( Dr Anton Buzdin - Sechenov Moscow First Medical University, Moscow, Russia )
10 Jul 2019

The value of personalised medicines for healthcare systems in Europe

Anthony Barron - European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
The value of personalised medicines for healthcare systems in Europe ( Anthony Barron - European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium )
10 Jul 2019

Decision support for precision oncology: Evolving from monotherapy to genomically informed combinations

Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA
Decision support for precision oncology: Evolving from monotherapy to genomically informed combinations ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )
10 Jul 2019

CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer

Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer ( Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan )
10 Jul 2019

Systems immunology in immuno-oncology

Dr Nikesh Kotecha - Parker Institute for Cancer Immunotherapy, San Francisco, USA
Systems immunology in immuno-oncology ( Dr Nikesh Kotecha - Parker Institute for Cancer Immunotherapy, San Francisco, USA )
10 Jul 2019

Highlights from WIN 2019

Prof Richard Schilsky - Chief Medical Officer of ASCO and WIN Chairman
Highlights from WIN 2019 ( Prof Richard Schilsky - Chief Medical Officer of ASCO and WIN Chairman )
10 Jul 2019

Innovation in clinical trials: WINTHER trial

Prof Razelle Kurzrock - University of California San Diego, San Diego, USA
Innovation in clinical trials: WINTHER trial ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )
10 Jul 2019

Data sharing and system interoperability: The Osiris French Program

Dr Pierre Saintigny - Centre Léon Bérard, Lyon, France
Data sharing and system interoperability: The Osiris French Program ( Dr Pierre Saintigny - Centre Léon Bérard, Lyon, France )
10 Jul 2019

RET inhibition in RET aberrant cancers

Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, USA
RET inhibition in RET aberrant cancers ( Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, USA )
10 Jul 2019

Goals of the WIN Consortium

Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA
Goals of the WIN Consortium ( Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA )
10 Jul 2019